- Report
- June 2024
- 371 Pages
Global
From €4399EUR$4,950USD£3,809GBP
- Report
- May 2023
United States
From €1067EUR$1,200USD£923GBP
€1333EUR$1,500USD£1,154GBP
- Report
- November 2022
- 197 Pages
United States
From €2666EUR$3,000USD£2,308GBP
€3333EUR$3,750USD£2,886GBP
- Report
- December 2021
- 353 Pages
Global
From €4888EUR$5,500USD£4,232GBP
- Report
- November 2023
- 157 Pages
Global
From €2089EUR$2,350USD£1,808GBP
- Report
- May 2024
- 311 Pages
Global
From €2177EUR$2,450USD£1,885GBP
- Report
- August 2023
- 336 Pages
Global
From €2444EUR$2,750USD£2,116GBP
€4888EUR$5,500USD£4,232GBP
- Report
- March 2022
- 273 Pages
Global
From €2333EUR$2,625USD£2,020GBP
€4666EUR$5,250USD£4,040GBP
- Report
- February 2024
- 77 Pages
Asia Pacific
From €2622EUR$2,950USD£2,270GBP
- Report
- January 2024
- 93 Pages
Europe
From €2622EUR$2,950USD£2,270GBP
- Report
- May 2023
- 240 Pages
Global
From €2444EUR$2,750USD£2,116GBP
€4888EUR$5,500USD£4,232GBP
- Report
- December 2021
- 296 Pages
Global
From €2333EUR$2,625USD£2,020GBP
€4666EUR$5,250USD£4,040GBP
- Report
- March 2024
- 145 Pages
Global
From €4133EUR$4,650USD£3,578GBP
- Report
- January 2023
- 131 Pages
Global
From €2222EUR$2,500USD£1,924GBP
- Report
- June 2023
- 155 Pages
Global
From €4133EUR$4,650USD£3,578GBP
- Report
- November 2023
- 183 Pages
United States
From €3511EUR$3,950USD£3,039GBP
- Report
- January 2023
- 103 Pages
Global
From €4399EUR$4,950USD£3,809GBP
- Report
- September 2022
- 94 Pages
Global
From €4399EUR$4,950USD£3,809GBP
- Report
- September 2022
- 62 Pages
Global
From €4399EUR$4,950USD£3,809GBP
- Report
- June 2021
- 77 Pages
Global
From €4399EUR$4,950USD£3,809GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more